Mavrova Anelia Ts, Yancheva Denitsa, Anastassova Neda, Anichina Kamelya, Zvezdanovic Jelena, Djordjevic Aleksandra, Markovic Dejan, Smelcerovic Andrija
Department of Organic Synthesis, University of Chemical Technology and Metallurgy, 8 Kliment Ohridski Blvd., 1756 Sofia, Bulgaria.
Institute of Organic Chemistry with Centre of Phytochemistry, Bulgarian Academy of Science, Acad. G Bonchev Str., Build. 9, 1113 Sofia, Bulgaria.
Bioorg Med Chem. 2015 Oct 1;23(19):6317-26. doi: 10.1016/j.bmc.2015.08.029. Epub 2015 Aug 28.
Two groups of benzimidazole derivatives were synthesized using as precursors 5(6)-substituted 2-mercapto-benzimidazol-thiols and their antioxidant activity was investigated using TBA-MDA test. In the group of 1,3-disubstituted-benzimidazol-2-imines the highest lipid peroxidation inhibition effect 74.04% (IC₅₀=141.89 μg/mL) revealed ethyl [3-(2-ethoxy-2-oxoethyl)-2-imino-5-benzoyl-2,3-dihydro-1H-benzimdazol-1-yl]acetate 12 while in the group of 2-substituted-1,3-thiazolo[3,2-a]benzimidazolones the highest inhibition effect showed 2-(4-fluorobenzylidene)-7-(phenylcarbonyl)[1,3]thiazolo[3,2-a]benzimidazol-3(2H)-one 17 90.76% (IC₅₀=53.70 μg/mL). In order to estimate the capability of the studied benzimidazoles to act as radical scavengers the structure of the most active derivative within the both subseries was optimized at B3LYP/6-311++G(∗∗) level and the respective bond dissociation enthalpies were calculated. The appropriate models for the HAT and SET-mechanism of the antioxidant activity were proposed. The antibacterial activity of the compounds was evaluated against two Gram-positive bacteria (Bacillus subtilis ATCC 6633 and Staphylococcus aureus ATCC 6538) and three Gram-negative bacteria (Escherichia coli ATCC 8739, Pseudomonas aeruginosa ATCC 9027 and Salmonella abony NCTC 6017). 1,3-Diphenylpropyl-5-methyl-1,3-dihydro-2H-benzimidazol-2-imine 14 exhibited significant activity against B. subtilis, S. aureus, S. abony and E. coli (with MIC values of 0.125, 0.016, 0.50 and 0.50mg/mL, respectively). The group of thiazolobenzimidazolones did not reveal antibacterial activity against the tested strains.
以5(6)-取代的2-巯基苯并咪唑硫醇为前体合成了两组苯并咪唑衍生物,并采用TBA-MDA试验研究了它们的抗氧化活性。在1,3-二取代苯并咪唑-2-亚胺组中,[3-(2-乙氧基-2-氧代乙基)-2-亚氨基-5-苯甲酰基-2,3-二氢-1H-苯并咪唑-1-基]乙酸乙酯12表现出最高的脂质过氧化抑制效果,为74.04%(IC₅₀=141.89 μg/mL);而在2-取代-1,3-噻唑并[3,2-a]苯并咪唑酮组中,2-(4-氟亚苄基)-7-(苯基羰基)[1,3]噻唑并[3,2-a]苯并咪唑-3(2H)-酮17表现出最高的抑制效果,为90.76%(IC₅₀=53.70 μg/mL)。为了评估所研究的苯并咪唑作为自由基清除剂的能力,在B3LYP/6-311++G(∗∗)水平上优化了两个子系列中最具活性衍生物的结构,并计算了相应的键解离焓。提出了抗氧化活性的HAT和SET机制的合适模型。评估了这些化合物对两种革兰氏阳性菌(枯草芽孢杆菌ATCC 6633和金黄色葡萄球菌ATCC 6538)和三种革兰氏阴性菌(大肠杆菌ATCC 8739、铜绿假单胞菌ATCC 9027和阿博尼沙门氏菌NCTC 6017)的抗菌活性。1,3-二苯基丙基-5-甲基-1,3-二氢-2H-苯并咪唑-2-亚胺14对枯草芽孢杆菌、金黄色葡萄球菌、阿博尼沙门氏菌和大肠杆菌表现出显著活性(MIC值分别为0.125、0.016、0.50和0.50mg/mL)。噻唑并苯并咪唑酮组对受试菌株未显示出抗菌活性。